No Detail Found!

Ketofol as induction agent in diabetic patients.

Author(s)
Aslam Samina Pain Management, Abwa Medical College, Faisalabad, Pakistan
Ahmad Humaira Pain Management, Abwa Medical College, Faisalabad, Pakistan
Hussain Muhammad Abwa Medical College, Faisalabad. Pakistan
Muhammad Rauf Independent Medical University, Faisalabad. Pakistan
Abstract
Objective: To evaluate the role of ketofol as induction agent in diabetic patients. Study Design: Randomized Control Trial. Setting: Department of Anesthesia, Abwa Medical College, Faisalabad. Period: Dec 2021 to May 2022. Material & Methods: Patients after informed consent divided randomly into two groups 25 in each. Group A receiving propofol 1.5 mg/kg and Group B receiving ketofol 1:2 as induction agent. The dose given was 1ml for every 5Kg. Standard 5 parameter monitoring with pulse oximetry, ECG, noninvasive BP done starting from preoperative to 2 minutes, 5 minutes and 10 minutes after induction agent given. MAP and HR were monitored. Hemodynamic instability was defined as I) Heart rate >160/min or 120mmHg or <60 mm Hg. Results: Total 50 patients included in this study. 25 in each group. The results show significant stability in hemodynamics in group B. Conclusion: Ketofol has better hemodynamic stability as induction agent in diabetic patients when used in a 2:1 ratio. This makes it a good choice for this specific patient population.
Publication Details
Page(s) 1476-1480
DOI DOI not available
Published Journal: Professional Medical Journal, Volume: 29, Issue: 10, Year: 2022

Request the full text from PASTIC

Keywords
Ketofol, Diabetes mellitus, Diabetes mellitus, Pulse Oximetry.
0

Citations

0

Downloads

122

Views